The HBOT Device Market in 2025: Growth Forecasts and the Wellness Surge
Analysts value the HBOT device market in the billions and forecast steady growth, driven partly by wellness and mild-chamber demand. The figures are estimates, not certainties.
A market measured in billions
The hyperbaric oxygen therapy device market has grown into a substantial global industry. Market-research firms generally place its value in the low single-digit billions of US dollars and forecast continued expansion through the end of the decade. Grand View Research, for example, estimated the global HBOT devices market at roughly 3.7 billion US dollars in 2024 and projected it to reach about 5.2 billion by 2030, implying a compound annual growth rate near 6 percent. Other firms, including Fortune Business Insights, publish their own estimates in a broadly similar range.
Reports also differ on what exactly they are counting. Some measure only the devices themselves, while others fold in the broader services market of clinics and treatment sessions, which widens the range of headline figures further. That is one reason two credible-looking numbers can sit billions of dollars apart.
Why the numbers vary
Anyone comparing reports quickly notices that the figures do not agree. Different firms report different base-year values, growth rates and end-year targets, with projected annual growth spanning roughly the mid-single digits to close to ten percent depending on the analyst. This spread is normal for market research: firms define the market differently, use different data sources and make different assumptions. The right way to read any single figure is as one analyst's estimate rather than a measured fact.
The wellness and mild-chamber surge
Beneath the headline totals, the more interesting story is where growth is expected to come from. Alongside the established clinical segment, which treats FDA-cleared conditions in hospitals and specialist centers, analysts point to a fast-expanding wellness segment. Demand for sports recovery, anti-aging and general wellness applications is repeatedly cited as a driver, and lighter, lower-pressure mild chambers aimed at clinics and home users are often forecast to grow faster than the market as a whole. This is also the segment where consumer marketing is most aggressive and where the underlying evidence is often weakest.
Some analysts single out mild, home-oriented systems as the fastest-growing niche, with projected growth rates well above the overall market, even though these devices operate at far lower pressures than clinical chambers. On the clinical side, expansion is tied to more prosaic drivers: an aging population, rising rates of diabetes and the chronic, non-healing wounds that HBOT is genuinely cleared to treat.
Reading forecasts with care
For buyers, that split is worth keeping in view. The wellness boom that fuels the forecasts is also the part of the market where claims tend to outrun the science, particularly around soft-sided systems; our overview of soft-sided mild chambers (soft-sided chambers) explains what those devices are and are not designed to do. Strong market growth says a great deal about demand and marketing, and very little about clinical effectiveness.
Market forecasts describe an industry, not a body of medical evidence. The fact that the HBOT device market is expanding does not by itself tell anyone whether the therapy is right for them. That remains a question for a qualified physician, weighed case by case rather than by market trend.